Anthony Chan

Associate

anthony-chan
  • PCLL, Chinese University of Hong Kong, 2009
  • LLB, London School of Economics and Political Science, 2008
  • BBA (Accounting & Finance), University of Hong Kong, 2003

Qualifications

  • Hong Kong, Solicitor, 2011
  • Chinese (Cantonese)
  • Chinese (Mandarin)
  • Law Society of Hong Kong
  • CFA Institute
  • CAIA Association

Anthony Chan

Associate

View the Chinese version. 

Anthony Chan is a senior associate in Ropes & Gray’s real estate investments & transactions practice, based in Hong Kong. Anthony focuses on advising private equity funds, private and public companies and financial investors in complex cross-border acquisitions and dispositions, joint ventures and other corporate transactions, particularly in the real estate sector.

Prior to joining the firm, Anthony has worked in Hong Kong and London for other leading international law firms.

Anthony holds the Chartered Financial Analyst (CFA) and Chartered Alternative Investment Analyst (CAIA) designation.

Experience

  • Represented a leading global private equity and alternative investment firm in the formation of a joint venture logistics platform with a listed Chinese real estate developer with respect to the development and/or acquisition of logistics properties across China, as well as the joint venture’s follow-on investments.*
  • Represented a leading global private equity and alternative investment firm in its acquisition of a portfolio of commercial and industrial properties in Nanhai, China from a listed Chinese conglomerate.*
  • Represented a leading global private equity and alternative investment firm in its acquisition of a retail property in Shanghai, China from a China-focused real estate investment fund.*
  • Represented a leading global private equity and alternative investment firm in the formation of a joint venture with a Hong Kong-based real estate developer with respect to the revamp of a retail property in Shanghai, China.*
  • Represented a leading global private equity and alternative investment firm in its disposition of a portfolio of commercial and retail properties across China to a listed Chinese real estate developer.*
  • Represented a leading global private equity and alternative investment firm in its disposition of a commercial and retail property in Beijing, China to a Chinese real estate developer.*
  • Represented a leading global private equity and alternative investment firm in the formation of a joint venture with a leading real estate developer in India with respect to the development of a portfolio of commercial properties in Pune, India.*
  • Represented a leading global private equity and alternative investment firm in a number of acquisitions and investments of real estate in India.*
  • Represented a leading global private equity and alternative investment firm in its US$651 million take-private transaction of Croesus Retail Trust, a Singapore-listed real estate investment trust holding a portfolio of retail properties in Japan.*
  • Represented Carlyle Asia in its HK$731 million subscription of convertible bonds and acquisition of a substantial interest in MicroPort Scientific Corporation, a Hong Kong-listed company.*
  • Represented a consortium of leading Asian-based private equity firms in its investment in a leading fiber optic network company in Cambodia and Myanmar.*
  • Represented Pacific Century Group in its acquisition of certain equity stake in Nova Founders Capital.*
  • Represented The Henley Group, in its sale to St. James's Place Wealth Management Group, a London-listed FTSE 100 company.*
  • Represented TPV Technology Limited, a Hong Kong listed company, in its acquisition of Philips’ television business in Europe and certain South American countries.*
  • Represented Bain Capital in its disposition of its substantial interests in GOME Electrical Appliances, a Hong Kong-listed company.*
  • Represented CITIC Private Equity in its HK$1.1 billion share sale in connection with the initial public offering of 3SBio Inc. in Hong Kong.*
  • Represented a private equity consortium (including CDH Capital, Citic Private Equity and New Horizon Capital) its US$330 million share sale in connection with the initial public offering of Luye Pharma Group Limited in Hong Kong.*
  • Represented Arsenal Capital in its sale of Novolyte Technologies to BASF.*
  • Represented the controlling shareholder of Jingwei Textile Machinery Company Limited, a company listed in Hong Kong and Shenzhen, in its HK$2,169.6 million voluntary conditional cash offer for all of the issued H shares.*
  • Represented the controlling shareholder of China Vanadium Titano-Magnetite Mining Company Limited in connection with its proposed privatization, through a scheme of arrangement.*
  • Represented Bank of America Merrill Lynch as financial adviser, in Oversea-Chinese Banking Corp Ltd's voluntary conditional cash offer for all the issued shares of Wing Hang Bank Ltd., a Hong Kong listed company.*
  • Represented Bank of America Merrill Lynch, as financial adviser, in CSR Corporation Limited's merger with China CNR Corporation Limited, a Hong Kong listed company.*
  • Represented China Traditional Chinese Medicine Co. Limited, a Hong Kong listed company, in its issuance of new shares to its controlling shareholder Sinopharm and two executive directors, and its share placement to 26 professional and institutional investors, for a total amount of HK$8.2 billion.*

*Transactions completed prior to joining Ropes & Gray

 
Cookie Settings